21 May 2012 12:11 PM, PDT | WENN | See recent WENN news »

A dozen addiction experts have mounted a legal campaign on behalf of actor Michael Douglas' incarcerated son Cameron, vowing to help the family fight his 54-month prison term.

Cameron Douglas is currently serving five years behind bars for drug distribution and heroin possession and last year he was handed an additional four-and-a-half-month jail term after he was caught with heroin and Suboxone, a prescription medication used to dull the effects of opioid withdrawal, in jail.

Douglas and his legal team subsequently lodged an appeal with the United States Court of Appeals for the Second Circuit, claiming his punishment was "shockingly long", and earlier this month a handful of doctors gave the 33 year old's case a boost by filing a supporting brief, insisting drug addiction is best treated with therapy, not prison time.

The group aims to help reduce or dismiss Douglas' 54-month sentence and push the corrections system into reiterating its stance on helping inmates with addiction, with Dr. Robert Newman writing, "My outrage is as a physician for someone who has a medical condition which has been ignored. What the judge has imposed has zero benefits for the community and has staggering consequences for society."

Michael Douglas and his lawyer, Nicholas M. De Feis, have been floored by the support of the top doctors.

De Feis tells The New York Times he and his client are "gratified that such a distinguished group of practitioners and experts have taken an interest in the case."

Report a problem

Similar News Items

Michael Douglas (I)
Cameron Douglas (I)

IMDb.com, Inc. takes no responsibility for the content or accuracy of the above news articles, Tweets, or blog posts. This content is published for the entertainment of our users only. The news articles, Tweets, and blog posts do not represent IMDb's opinions nor can we guarantee that the reporting therein is completely factual. Please visit the source responsible for the item in question to report any concerns you may have regarding content or accuracy.

See our NewsDesk partners